Development of a new metastatic human breast carcinoma xenograft line
1998

New Metastatic Human Breast Carcinoma Xenograft Line

Sample size: 5 publication 10 minutes Evidence: high

Author Information

Author(s): RR Mehta, JM Graves, A Shilkaitis, TK Das Gupta

Primary Institution: University of Illinois at Chicago

Hypothesis

Can a new human breast carcinoma xenograft line be developed that shows high tumorigenicity and metastatic potential?

Conclusion

The UISO-BCA-NMT-18 xenograft line demonstrates 100% tumorigenicity and 80-100% lung metastasis, making it a valuable model for breast cancer research.

Supporting Evidence

  • The xenograft line shows 100% tumorigenicity in athymic mice.
  • 80-100% of the xenografts developed lung metastasis.
  • The xenograft is responsive to exogenous estrogen.
  • Immunohistochemical analysis showed intense staining for mutant p53 and high expression of U-PA, PAI, and u-PAR.

Takeaway

Scientists created a new type of breast cancer model that grows tumors and spreads in mice, which can help them study how breast cancer works.

Methodology

The study involved creating a xenograft from a primary human breast carcinoma using enzymatic digestion and Matrigel, followed by serial transplantation in athymic mice.

Limitations

The study primarily focused on a single xenograft line and its characteristics, which may not represent all breast cancer types.

Participant Demographics

The original tumor was obtained from a 41-year-old woman with primary breast carcinoma.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication